5 Oct 2026, 08:24
Company UpdateMS
1ADADALTA LIMITED
Announcement history available from 1 August 2025
Fromto
1 Oct 2026, 08:42
Company UpdateMS
30 Sept 2026, 09:45
Meetings & Governance—
23 Sept 2026, 08:17
Company UpdateMS
18 Sept 2026, 09:52
Company UpdateMS
15 Sept 2026, 08:22
Company Administration—
10 Sept 2026, 09:49
Presentations—
2 Sept 2026, 09:30
Company UpdateMS
21 Aug 2026, 17:00
Company Administration—
21 Aug 2026, 16:58
Financial Results—
21 Aug 2026, 16:54
Financial ResultsMS
13 Aug 2026, 09:21
Presentations—
10 Aug 2026, 09:18
Company UpdateMS
5 Aug 2026, 08:26
Company UpdateMS
29 July 2026, 09:23
Quarterly ReportsMS
20 July 2026, 09:38
Presentations—
14 July 2026, 08:49
Company Update—
2 July 2026, 09:16
Securities Administration—
2 July 2026, 09:14
Securities Administration—
2 July 2026, 09:13
Securities Administration—
2 July 2026, 08:23
Company UpdateMS
1 July 2026, 09:03
Company UpdateMS
25 June 2026, 15:52
Securities Administration—
25 June 2026, 15:50
Securities Administration—
15 June 2026, 17:56
Meetings & Governance—
9 June 2026, 08:32
Meetings & Governance—
25 May 2026, 08:53
Securities Administration—
25 May 2026, 08:51
Other—
25 May 2026, 08:44
Capital RaisingMS
25 May 2026, 08:17
Company UpdateMS
18 May 2026, 09:38
Securities Administration—
18 May 2026, 08:55
Securities Administration—
15 May 2026, 09:41
Meetings & Governance—
11 May 2026, 12:12
Presentations—
7 May 2026, 08:25
Presentations—
4 May 2026, 13:57
Securities Administration—
4 May 2026, 09:48
Securities Administration—
4 May 2026, 09:47
Capital RaisingMS
30 Apr 2026, 08:49
Trading Halt / SuspensionMS
30 Apr 2026, 08:31
Quarterly ReportsMS
29 Apr 2026, 08:23
Company UpdateMS
21 Apr 2026, 09:17
Company UpdateMS
17 Apr 2026, 09:40
Company Administration—
2 Apr 2026, 14:07
Securities Administration—
1 Apr 2026, 09:20
Company UpdateMS
27 Mar 2026, 09:46
Company UpdateMS
20 Mar 2026, 09:49
Company UpdateMS
18 Mar 2026, 09:20
Company Administration—
18 Mar 2026, 09:19
Director Interests—
4 Mar 2026, 08:29
Company AdministrationMS
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 5 Oct 2026, 08:24 | EW-001 JDC milestone approvals | Company Update | MS | 11001 | |
| 1 Oct 2026, 08:42 | China Representative Office opens | Company Update | MS | 11001, 12008 | |
| 30 Sept 2026, 09:45 | Date of AGM & Closing Date for Director Nominations | Meetings & Governance | — | 08006 | |
| 23 Sept 2026, 08:17 | US FDA grants EW-001 pre-IND meeting | Company Update | MS | 11001 | |
| 18 Sept 2026, 09:52 | Oribiotech deal validates AdAlta manufacturing strategy | Company Update | MS | 11001 | |
| 15 Sept 2026, 08:22 | CAR-TCR Summit poster | Company Administration | — | 12008 | |
| 10 Sept 2026, 09:49 | Bilingual BIOSeedin Investor Presentation | Presentations | — | 03026 | |
| 2 Sept 2026, 09:30 | BZDS1901 special access scheme launch in China | Company Update | MS | 11001 | |
| 21 Aug 2026, 17:00 | Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 21 Aug 2026, 16:58 | Annual Report to shareholders | Financial Results | — | 03001, 03002, 03011, 03012, 03013, 03020 | |
| 21 Aug 2026, 16:54 | Preliminary Final Report | Financial Results | MS | 03003 | |
| 13 Aug 2026, 09:21 | Investor presentation | Presentations | — | 03026 | |
| 10 Aug 2026, 09:18 | EW-001 IIT study overall survival update | Company Update | MS | 11001 | |
| 5 Aug 2026, 08:26 | 2 year survival milestone for EW-001 patient | Company Update | MS | 11001 | |
| 29 July 2026, 09:23 | Quarterly Appendix 4C and Activities Report | Quarterly Reports | MS | 19004, 19009 | |
| 20 July 2026, 09:38 | ISCTANZ2026 presentation and poster | Presentations | — | 03026, 14014 | |
| 14 July 2026, 08:49 | ISCT poster awarded oral presentation | Company Update | — | 11001 | |
| 2 July 2026, 09:16 | Cleansing Notice | Securities Administration | — | 06018 | |
| 2 July 2026, 09:14 | Application for quotation of securities - 1AD | Securities Administration | — | 06020 | |
| 2 July 2026, 09:13 | Application for quotation of securities - 1AD | Securities Administration | — | 06020 | |
| 2 July 2026, 08:23 | Oktopi AI collaboration for research efficiency | Company Update | MS | 11001 | |
| 1 July 2026, 09:03 | Second BZDS1901 milestone paid | Company Update | MS | 11001 | |
| 25 June 2026, 15:52 | Cleansing Notice | Securities Administration | — | 06018 | |
| 25 June 2026, 15:50 | Application for quotation of securities - 1AD | Securities Administration | — | 06020 | |
| 15 June 2026, 17:56 | Results of Meeting | Meetings & Governance | — | 08003 | |
| 9 June 2026, 08:32 | Confirmation of results of Prospectus Offer | Meetings & Governance | — | 06009, 08006 | |
| 25 May 2026, 08:53 | Proposed issue of securities - 1AD | Securities Administration | — | 06013 | |
| 25 May 2026, 08:51 | Target Market Determination | Other | — | 14001 | |
| 25 May 2026, 08:44 | Prospectus | Capital Raising | MS | 06003, 06010 | |
| 25 May 2026, 08:17 | Regulatory advisors appointed for BZDS1901 | Company Update | MS | 11001 | |
| 18 May 2026, 09:38 | Cleansing Notice | Securities Administration | — | 06018 | |
| 18 May 2026, 08:55 | Application for quotation of securities - 1AD | Securities Administration | — | 06020 | |
| 15 May 2026, 09:41 | Notice of EGM & Proxy Form | Meetings & Governance | — | 08002, 08004 | |
| 11 May 2026, 12:12 | Webinar presentation - new hope for mesothelioma patients | Presentations | — | 03026 | |
| 7 May 2026, 08:25 | Investor webinar - new hope for mesothelioma patients | Presentations | — | 14014 | |
| 4 May 2026, 13:57 | Proposed issue of securities - 1AD | Securities Administration | — | 06013 | |
| 4 May 2026, 09:48 | Proposed issue of securities - 1AD | Securities Administration | — | 06013 | |
| 4 May 2026, 09:47 | $2.5m placement | Capital Raising | MS | 06003, 09014 | |
| 30 Apr 2026, 08:49 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 30 Apr 2026, 08:31 | Quarterly Appendix 4C and Activities Report | Quarterly Reports | MS | 19003, 19008 | |
| 29 Apr 2026, 08:23 | BZDS1901 manufacturing agreement | Company Update | MS | 11001 | |
| 21 Apr 2026, 09:17 | Automated cell therapy manufacturing MoU | Company Update | MS | 11001 | |
| 17 Apr 2026, 09:40 | Board Change and Appendix 3Z | Company Administration | — | 02010, 12001 | |
| 2 Apr 2026, 14:07 | Notification of cessation of securities - 1AD | Securities Administration | — | 06027 | |
| 1 Apr 2026, 09:20 | BZDS1901 clinical update | Company Update | MS | 11001 | |
| 27 Mar 2026, 09:46 | AdCella and SHcell hold first JDC meeting | Company Update | MS | 11001 | |
| 20 Mar 2026, 09:49 | New AD-214 patent granted | Company Update | MS | 11001 | |
| 18 Mar 2026, 09:20 | Fadi Diab to join AdAlta Board | Company Administration | — | 12001 | |
| 18 Mar 2026, 09:19 | Initial Director's Interest Notice (FD) | Director Interests | — | 02008 | |
| 4 Mar 2026, 08:29 | AdCella expands clinical advisory board | Company Administration | MS | 12008 |
1–50 of 123
1 / 3